Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rituximab in secondary progressive multiple sclerosis: a meta-analysis.

  • Authors : Intarakhao P; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Laipasu T

Subjects: Immunologic Factors*/Immunologic Factors*/Immunologic Factors*/pharmacology ; Immunologic Factors*/Immunologic Factors*/Immunologic Factors*/therapeutic use ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Oct; Vol. 11 (10), pp. 2707-2718. Date of Electronic Publication: 2024 Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.

  • Authors : Abdelhak A; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA.; Department of Neurology, University Hospital of Ulm, Ulm, Germany.

Subjects: Multiple Sclerosis* ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/diagnosis; Female

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Feb; Vol. 11 (2), pp. 477-485. Date of Electronic Publication: 2023 Dec Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review.

  • Authors : Montalban X; Department of Neurology, Centre d'Esclerosi Mútiple de Catalunya (Cemcat), Barcelona, Spain.; Matthews PM

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy ; Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/Multiple Sclerosis, Chronic Progressive*/drug therapy

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Mar; Vol. 10 (3), pp. 302-311. Date of Electronic Publication: 2023 Feb Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Clinical relevance of paramagnetic rim lesion heterogeneity in multiple sclerosis.

  • Authors : Stölting A; Neuroinflammation Imaging Lab (NIL), Institute of NeuroScience, Université catholique de Louvain, Brussels, Belgium.; Vanden Bulcke C

Subjects: Magnetic Resonance Imaging*; Humans ; Female

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Dec; Vol. 11 (12), pp. 3137-3151. Date of Electronic Publication: 2024 Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.

  • Authors : Newsome SD; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Goldstick L

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacokinetics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Dec; Vol. 11 (12), pp. 3215-3226. Date of Electronic Publication: 2024 Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis.

  • Authors : Madill E; Brigham Multiple Sclerosis Center, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Subjects: Glial Fibrillary Acidic Protein*/Glial Fibrillary Acidic Protein*/Glial Fibrillary Acidic Protein*/blood ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/blood ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/physiopathology

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Oct; Vol. 11 (10), pp. 2719-2730. Date of Electronic Publication: 2024 Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Investigating cortical hypoxia in multiple sclerosis via time-domain near-infrared spectroscopy.

  • Authors : Williams T; UCL Queen Square Institute of Neurology, University College London, London, UK.; Lange F

Subjects: Spectroscopy, Near-Infrared*/Spectroscopy, Near-Infrared*/Spectroscopy, Near-Infrared*/methods ; Prefrontal Cortex*/Prefrontal Cortex*/Prefrontal Cortex*/diagnostic imaging ; Prefrontal Cortex*/Prefrontal Cortex*/Prefrontal Cortex*/metabolism

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Sep; Vol. 11 (9), pp. 2372-2381. Date of Electronic Publication: 2024 Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Development of an age-adjusted model for blood neurofilament light chain.

  • Authors : Harp C; Genentech, Inc., South San Francisco, California, USA.; Thanei GA

Subjects: Multiple Sclerosis* ; Multiple Sclerosis, Chronic Progressive*; Adult

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Apr; Vol. 9 (4), pp. 444-453. Date of Electronic Publication: 2022 Mar Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine.

  • Authors : Krysko KM; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.; Division of Neurology, Department of Medicine, St. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.

Subjects: Acetylcysteine/Acetylcysteine/Acetylcysteine/*pharmacology ; Fatigue/Fatigue/Fatigue/*drug therapy ; Fatigue/Fatigue/Fatigue/*metabolism

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Apr; Vol. 8 (4), pp. 811-824. Date of Electronic Publication: 2021 Mar Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
Academic Journal

Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures.

  • Authors : Tripathi A; Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA.; Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.

Subjects: Gene Expression Profiling* ; Protein Interaction Maps*; Gray Matter/Gray Matter/Gray Matter/*metabolism

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jun; Vol. 8 (6), pp. 1279-1291. Date of Electronic Publication: 2021 MayPublisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

تفاصيل العنوان

×
  • 1-10 ل  52 نتائج ل ""Chronic Progressive""